Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients

The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, a...

Full description

Saved in:
Bibliographic Details
Published inSchizophrenia bulletin Vol. 17; no. 4; pp. 597 - 608
Main Authors Benes, F. M., Sorensen, I., Bird, E. D.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.01.1991
National Institute of Mental Health
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, as well as the number, size, and degree of disarray of pyramidal neurons were present in 9 control and 14 schizophrenic subjects. Seven schizophrenic patients showed evidence of superimposed mood disturbance (schizoaffective type), while the remaining seven were a mixture of paranoid, undifferentiated, and catatonic types. All morphometric measurements were conducted under strictly blind conditions; stepwise multiple regression and analyses of covariance were used to evaluate the effects of various confounding variables. There were no differences in the cross-sectional size of the hippocampus or degree of neuronal disarray between the two groups. Similarly, the number of pyramidal neurons was also the same in sectors Cornu Ammonis (CA) 2, CA 3, and CA 4 for the controls and schizophrenic subjects. In CA 1, the schizophrenic subjects without mood disturbances showed a significant reduction (36%) of pyramidal neuron numbers when compared with those of both controls and patients with mood disturbance. Pyramidal neurons were smaller in all sectors of the schizophrenic specimens, CA 1 (p less than or equal to 0.01), CA 2 (p less than or equal to 0.01), CA 3 (p less than or equal to 0.01), and CA 4 (p less than or equal to 0.005), but there were no differences with respect to the presence of mood disturbances. Corrections for the effects of age, postmortem interval, fixation interval, hypoxia, and neuroleptic exposure did not alter the pattern in the data. The significance of a smaller size of hippocampal pyramidal neurons in this group of schizophrenic specimens is unclear, but it is consistent with the suggestions of other laboratories that there may be altered function of this brain region in chronically psychotic individuals.
AbstractList The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, as well as the number, size, and degree of disarray of pyramidal neurons were present in 9 control and 14 schizophrenic subjects. Seven schizophrenic patients showed evidence of superimposed mood disturbance (schizoaffective type), while the remaining seven were a mixture of paranoid, undifferentiated, and catatonic types. All morphometric measurements were conducted under strictly blind conditions; stepwise multiple regression and analyses of covariance were used to evaluate the effects of various confounding variables. There were no differences in the cross-sectional size of the hippocampus or degree of neuronal disarray between the two groups. Similarly, the number of pyramidal neurons was also the same in sectors Cornu Ammonis (CA) 2, CA 3, and CA 4 for the controls and schizophrenic subjects. In CA 1, the schizophrenic subjects without mood disturbances showed a significant reduction (36%) of pyramidal neuron numbers when compared with those of both controls and patients with mood disturbance. Pyramidal neurons were smaller in all sectors of the schizophrenic specimens, CA 1 (p <: 0.01), CA 2 (p <: 0.01), CA 3 (p <, 0.01), and CA 4 (p <, 0.005), but there were no differences with respect to the presence of mood disturbances. Corrections for the effects of age, postmortem interval, fixation interval, hypoxia, and neuroleptic exposure did not alter the pattern in the data. The significance of a smaller size of hippocampal pyramidal neurons in this group of schizophrenic specimens is unclear, but it is consistent with the suggestions of other laboratories that there may be altered function of this brain region in chronically psychotic individuals. (PsycINFO Database Record (c) 2016 APA, all rights reserved) (Source: journal abstract)
The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, as well as the number, size, and degree of disarray of pyramidal neurons were present in 9 control and 14 schizophrenic subjects. Seven schizophrenic patients showed evidence of superimposed mood disturbance (schizoaffective type), while the remaining seven were a mixture of paranoid, undifferentiated, and catatonic types. All morphometric measurements were conducted under strictly blind conditions; stepwise multiple regression and analyses of covariance were used to evaluate the effects of various confounding variables. There were no differences in the cross-sectional size of the hippocampus or degree of neuronal disarray between the two groups. Similarly, the number of pyramidal neurons was also the same in sectors Cornu Ammonis (CA) 2, CA 3, and CA 4 for the controls and schizophrenic subjects. In CA 1, the schizophrenic subjects without mood disturbances showed a significant reduction (36%) of pyramidal neuron numbers when compared with those of both controls and patients with mood disturbance. Pyramidal neurons were smaller in all sectors of the schizophrenic specimens, CA 1 (p less than or equal to 0.01), CA 2 (p less than or equal to 0.01), CA 3 (p less than or equal to 0.01), and CA 4 (p less than or equal to 0.005), but there were no differences with respect to the presence of mood disturbances. Corrections for the effects of age, postmortem interval, fixation interval, hypoxia, and neuroleptic exposure did not alter the pattern in the data. The significance of a smaller size of hippocampal pyramidal neurons in this group of schizophrenic specimens is unclear, but it is consistent with the suggestions of other laboratories that there may be altered function of this brain region in chronically psychotic individuals.The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, as well as the number, size, and degree of disarray of pyramidal neurons were present in 9 control and 14 schizophrenic subjects. Seven schizophrenic patients showed evidence of superimposed mood disturbance (schizoaffective type), while the remaining seven were a mixture of paranoid, undifferentiated, and catatonic types. All morphometric measurements were conducted under strictly blind conditions; stepwise multiple regression and analyses of covariance were used to evaluate the effects of various confounding variables. There were no differences in the cross-sectional size of the hippocampus or degree of neuronal disarray between the two groups. Similarly, the number of pyramidal neurons was also the same in sectors Cornu Ammonis (CA) 2, CA 3, and CA 4 for the controls and schizophrenic subjects. In CA 1, the schizophrenic subjects without mood disturbances showed a significant reduction (36%) of pyramidal neuron numbers when compared with those of both controls and patients with mood disturbance. Pyramidal neurons were smaller in all sectors of the schizophrenic specimens, CA 1 (p less than or equal to 0.01), CA 2 (p less than or equal to 0.01), CA 3 (p less than or equal to 0.01), and CA 4 (p less than or equal to 0.005), but there were no differences with respect to the presence of mood disturbances. Corrections for the effects of age, postmortem interval, fixation interval, hypoxia, and neuroleptic exposure did not alter the pattern in the data. The significance of a smaller size of hippocampal pyramidal neurons in this group of schizophrenic specimens is unclear, but it is consistent with the suggestions of other laboratories that there may be altered function of this brain region in chronically psychotic individuals.
The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This article has employed quantitative morphometric techniques to determine whether abnormalities of posterior hippocampal cross-sectional area, as well as the number, size, and degree of disarray of pyramidal neurons were present in 9 control and 14 schizophrenic subjects. Seven schizophrenic patients showed evidence of superimposed mood disturbance (schizoaffective type), while the remaining seven were a mixture of paranoid, undifferentiated, and catatonic types. All morphometric measurements were conducted under strictly blind conditions; stepwise multiple regression and analyses of covariance were used to evaluate the effects of various confounding variables. There were no differences in the cross-sectional size of the hippocampus or degree of neuronal disarray between the two groups. Similarly, the number of pyramidal neurons was also the same in sectors Cornu Ammonis (CA) 2, CA 3, and CA 4 for the controls and schizophrenic subjects. In CA 1, the schizophrenic subjects without mood disturbances showed a significant reduction (36%) of pyramidal neuron numbers when compared with those of both controls and patients with mood disturbance. Pyramidal neurons were smaller in all sectors of the schizophrenic specimens, CA 1 (p less than or equal to 0.01), CA 2 (p less than or equal to 0.01), CA 3 (p less than or equal to 0.01), and CA 4 (p less than or equal to 0.005), but there were no differences with respect to the presence of mood disturbances. Corrections for the effects of age, postmortem interval, fixation interval, hypoxia, and neuroleptic exposure did not alter the pattern in the data. The significance of a smaller size of hippocampal pyramidal neurons in this group of schizophrenic specimens is unclear, but it is consistent with the suggestions of other laboratories that there may be altered function of this brain region in chronically psychotic individuals.
Author Benes, F. M.
Sorensen, I.
Bird, E. D.
Author_xml – sequence: 1
  givenname: F. M.
  surname: Benes
  fullname: Benes, F. M.
– sequence: 2
  givenname: I.
  surname: Sorensen
  fullname: Sorensen, I.
– sequence: 3
  givenname: E. D.
  surname: Bird
  fullname: Bird, E. D.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5098486$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/1805353$$D View this record in MEDLINE/PubMed
BookMark eNp1kUFrGzEUhEVxSO2k554KSwm5rS2tpNXusZgmLpgkJO1ZyG-fsMJa2kq7h-bXV8GmhUBO7zDfDLyZBZn54JGQz4wuGW35KsF-N_UrppZiKVv1gcyZErJkirIZmVPZ1KWqmfhIFik9U8pEW1fn5Jw1VHLJ52TziN0E2BV3OMXgTV88uRcsnC8eQhoxuhCLjRuGAOYwTKkItniCvXsJwz6id1A8mNGhH9MlObOmT_jpdC_Ir5vvP9ebcnt_-2P9bVsCb9qxtC1IJeiuscxKIaoWkBkDXO0smk52lPPaCquQ11ChqBSAQsOztzIdMMovyPUxd4jh94Rp1AeXAPveeAxT0qpSTFT8Ffz6BnwOU8wfJp0LEawRnGfoywmadgfs9BDdwcQ_-tRP1q9OuklgehuNB5f-YZK2jWjqjK2OGMSQUkT7P4jq1530cSfNlBY675Qd8o0D3JirDH6MxvXv-v4C9ymY7Q
CODEN SCZBB3
CitedBy_id crossref_primary_10_1016_S0920_9964_00_00084_0
crossref_primary_10_1016_j_neuroscience_2004_07_047
crossref_primary_10_1176_ajp_154_6_812
crossref_primary_10_31887_DCNS_2000_2_4_pharrison
crossref_primary_10_1007_s00702_023_02650_5
crossref_primary_10_1016_j_schres_2014_12_006
crossref_primary_10_1073_pnas_95_19_11406
crossref_primary_10_1016_S0006_3223_00_01120_3
crossref_primary_10_1586_14737175_5_1_85
crossref_primary_10_1016_j_bbi_2015_08_021
crossref_primary_10_1016_S0925_4927_01_00108_1
crossref_primary_10_1111_j_1460_9568_2012_08204_x
crossref_primary_10_1016_j_semcdb_2011_07_007
crossref_primary_10_1097_00001504_200304002_00004
crossref_primary_10_1016_S0193_953X_05_70361_0
crossref_primary_10_1016_j_biopsych_2004_03_002
crossref_primary_10_1080_09602011_2017_1369888
crossref_primary_10_1016_0920_9964_93_90057_P
crossref_primary_10_1038_npp_2011_219
crossref_primary_10_1177_070674379604100710
crossref_primary_10_1016_j_brainresrev_2006_12_008
crossref_primary_10_1016_S0006_3223_00_01052_0
crossref_primary_10_1097_CHI_Ob013e318172ef36
crossref_primary_10_1523_JNEUROSCI_0501_11_2011
crossref_primary_10_1176_appi_ajp_157_7_1141
crossref_primary_10_1016_S1359_1789_03_00046_6
crossref_primary_10_1007_s00221_018_5187_5
crossref_primary_10_1016_j_schres_2004_08_018
crossref_primary_10_1088_1612_2011_13_8_085603
crossref_primary_10_1007_s10571_006_9128_7
crossref_primary_10_1176_jnp_9_3_460
crossref_primary_10_1016_S0014_2999_00_00568_9
crossref_primary_10_1002_hipo_20873
crossref_primary_10_1038_mp_2014_47
crossref_primary_10_1111_j_1749_6632_1999_tb09288_x
crossref_primary_10_1016_S0278_5846_96_00158_3
crossref_primary_10_1002__SICI_1096_9861_19960401_367_2_274__AID_CNE9_3_0_CO_2_2
crossref_primary_10_31887_DCNS_2001_3_4_ebramon
crossref_primary_10_1016_S0022_3956_96_00042_8
crossref_primary_10_1038_npp_2017_5
crossref_primary_10_1038_sj_mp_4001558
crossref_primary_10_1038_npp_2009_111
crossref_primary_10_1016_j_pscychresns_2012_10_005
crossref_primary_10_1002__SICI_1096_9861_19980316_392_3_402__AID_CNE9_3_0_CO_2_5
crossref_primary_10_1002_hipo_1067
crossref_primary_10_1080_000486700231
crossref_primary_10_1016_S0301_0511_01_00114_4
crossref_primary_10_1080_15622970410029903
crossref_primary_10_1002_hipo_1065
crossref_primary_10_1007_s00429_005_0035_3
crossref_primary_10_1517_17460440902762794
crossref_primary_10_31887_DCNS_2000_2_3_hgrunze
crossref_primary_10_1016_S0166_4328_96_00132_5
crossref_primary_10_1111_j_1749_6632_2000_tb06732_x
crossref_primary_10_1038_nrn3785
crossref_primary_10_1016_0006_3223_93_90253_A
crossref_primary_10_1016_j_celrep_2015_03_022
crossref_primary_10_1016_S0006_8993_97_00575_1
crossref_primary_10_3389_fnins_2021_766802
crossref_primary_10_1016_S0025_7125_05_70335_7
crossref_primary_10_1007_s00406_007_0733_3
crossref_primary_10_1016_j_schres_2009_07_022
crossref_primary_10_1007_BF02191801
crossref_primary_10_1177_000486740003401S17
crossref_primary_10_1176_ajp_155_11_1536
crossref_primary_10_1016_j_pscychresns_2018_03_008
crossref_primary_10_1002_hipo_1074
crossref_primary_10_1111_j_1749_6632_1999_tb09290_x
crossref_primary_10_1016_S0962_1849_98_80021_8
crossref_primary_10_1002_hipo_1070
crossref_primary_10_1016_S0006_8993_97_00113_3
crossref_primary_10_1186_1471_2350_15_37
crossref_primary_10_1016_j_ajp_2020_102370
crossref_primary_10_1016_j_biopsych_2005_09_021
crossref_primary_10_1016_0006_3223_94_00252_X
crossref_primary_10_1176_ajp_154_1_56
crossref_primary_10_1176_appi_ajp_2010_10050681
crossref_primary_10_1046_j_1440_1614_2000_00788_x
crossref_primary_10_1016_S0140_6736_98_03341_8
crossref_primary_10_1016_j_pneurobio_2011_04_003
crossref_primary_10_1038_sj_mp_4001656
crossref_primary_10_1016_0006_3223_94_00128_P
crossref_primary_10_1016_j_eurpsy_2004_06_020
crossref_primary_10_1017_S1134066500003866
crossref_primary_10_3390_foods13223639
crossref_primary_10_1016_S0006_3223_01_01084_8
crossref_primary_10_1002__SICI_1098_2396_199911_34_2_95__AID_SYN2_3_0_CO_2_I
crossref_primary_10_1016_0304_3940_94_90192_9
crossref_primary_10_1177_1073858418824072
crossref_primary_10_1111_pcn_12957
crossref_primary_10_1007_BF03033065
crossref_primary_10_1176_ajp_156_11_1720
crossref_primary_10_1038_sj_npp_1300710
crossref_primary_10_1016_j_schres_2007_04_034
crossref_primary_10_1016_S0920_9964_99_00068_7
crossref_primary_10_1016_j_plefa_2006_07_010
crossref_primary_10_1126_science_1070532
crossref_primary_10_1176_ajp_157_1_40
crossref_primary_10_1016_S0925_4927_02_00026_4
crossref_primary_10_1016_S0014_2999_99_00059_X
crossref_primary_10_1080_j_1440_1614_2006_01877_x
crossref_primary_10_1016_0014_2999_96_00204_X
crossref_primary_10_1007_s00401_008_0430_y
crossref_primary_10_1586_14737175_8_7_1049
crossref_primary_10_1016_S0304_3940_01_01637_8
crossref_primary_10_1111_1365_2435_12125
crossref_primary_10_1111_j_1600_0447_1999_tb05982_x
crossref_primary_10_1016_S0006_3223_02_01327_6
crossref_primary_10_1016_j_bbr_2011_07_033
crossref_primary_10_1038_s41380_020_0853_y
crossref_primary_10_1017_S0954579400004752
crossref_primary_10_1111_j_1440_1789_1998_tb00106_x
crossref_primary_10_33549_physiolres_935501
crossref_primary_10_1176_ajp_152_5_738
crossref_primary_10_1016_j_neuroimage_2004_07_025
crossref_primary_10_1093_schbul_sbaa099
crossref_primary_10_1016_j_ijdevneu_2015_02_001
crossref_primary_10_1192_bjp_166_5_563
crossref_primary_10_1016_S0006_3223_01_01121_0
crossref_primary_10_1016_S0920_9964_01_00163_3
crossref_primary_10_1038_srep19106
crossref_primary_10_1006_nbdi_2002_0548
crossref_primary_10_3389_fnmol_2020_00040
crossref_primary_10_1196_annals_1397_077
crossref_primary_10_1097_00001756_199711100_00037
crossref_primary_10_1016_j_biopsych_2003_12_015
crossref_primary_10_1016_S0896_6273_00_00111_2
crossref_primary_10_1016_S1566_2772_03_00022_7
crossref_primary_10_1093_brain_122_4_593
crossref_primary_10_1016_S0022_3956_96_00044_1
crossref_primary_10_1136_jnnp_2018_319396
crossref_primary_10_1016_0014_2999_94_00629_L
crossref_primary_10_1016_j_schres_2024_11_009
crossref_primary_10_1016_S0006_3223_97_00024_3
crossref_primary_10_1016_j_bbr_2006_03_014
crossref_primary_10_1080_00048670902721103
crossref_primary_10_1093_schbul_sbp039
crossref_primary_10_1016_S0920_9964_01_00188_8
crossref_primary_10_1002__SICI_1096_9861_19960401_367_2_293__AID_CNE10_3_0_CO_2_S
crossref_primary_10_1016_0006_3223_94_00257_4
crossref_primary_10_3109_15622970902806124
crossref_primary_10_1016_j_neuroimage_2003_11_011
crossref_primary_10_1016_S0246_1072_03_00109_3
crossref_primary_10_1016_S0278_5846_99_00005_6
crossref_primary_10_1176_appi_ajp_160_12_2190
crossref_primary_10_1016_S0168_0102_02_00023_8
crossref_primary_10_1016_S0006_3223_98_00138_3
crossref_primary_10_1038_sj_mp_4001985
crossref_primary_10_31887_DCNS_2000_2_3_sheckers
crossref_primary_10_3389_fnbeh_2014_00088
crossref_primary_10_1016_0006_8993_94_01384_T
crossref_primary_10_1016_S0006_3223_98_00331_X
crossref_primary_10_1016_j_schres_2012_12_019
crossref_primary_10_1016_S0006_3223_99_00136_5
crossref_primary_10_1007_BF01474687
crossref_primary_10_1016_0091_3057_92_90503_8
crossref_primary_10_1016_0920_9964_94_90033_7
crossref_primary_10_1016_S0169_328X_99_00185_0
crossref_primary_10_1038_sj_npp_1300120
crossref_primary_10_1111_j_1440_1819_1994_tb03003_x
crossref_primary_10_1111_j_1440_1681_2005_04257_x
crossref_primary_10_1016_j_nbd_2013_07_008
crossref_primary_10_1016_j_neulet_2004_12_079
crossref_primary_10_1016_S0165_0173_99_00053_3
crossref_primary_10_1016_j_bpsc_2018_02_001
crossref_primary_10_1007_PL00010683
crossref_primary_10_1016_0920_9964_93_90002_Z
crossref_primary_10_1109_TMI_2014_2382581
crossref_primary_10_1590_S0101_60832012005000007
crossref_primary_10_1016_S0920_9964_97_00067_4
crossref_primary_10_1002_syn_20153
crossref_primary_10_1016_S0193_953X_18_30174_6
crossref_primary_10_1192_bjp_183_5_414
ContentType Journal Article
Copyright 1992 INIST-CNRS
Copyright_xml – notice: 1992 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7RZ
PHGZM
PHGZT
PKEHL
PSYQQ
7X8
DOI 10.1093/schbul/17.4.597
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest PsycARTICLES
ProQuest Central Premium
ProQuest One Academic
ProQuest One Academic Middle East (New)
ProQuest One Psychology
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest One Academic Middle East (New)
ProQuest Central (New)
PsycARTICLES
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1745-1701
EndPage 608
ExternalDocumentID 1805353
5098486
10_1093_schbul_17_4_597
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: MH-31862
– fundername: NIMH NIH HHS
  grantid: MH-42261
– fundername: NIMH NIH HHS
  grantid: MH-00423
GroupedDBID ---
-E4
-~X
.2P
.GJ
.I3
.ZR
0R~
123
186
18M
1TH
2WC
4.4
48X
53G
5RE
5VS
5WA
7RZ
85S
AAMDB
AAMVS
AAOGV
AAWTL
AAYXX
ABEJV
ABEUO
ABGNP
ABIVO
ABJNI
ABLJU
ABNCP
ABOCM
ABPPZ
ABPTD
ABQLI
ABSMQ
ABVOZ
ACFRR
ACGFO
ACGFS
ACGOD
ACHQT
ACNCT
ACPQG
ACUFI
ACUTJ
ACUTO
ACVCV
ADHZD
ADZXQ
AEGXH
AEHFB
AEMDU
AENEX
AETEA
AFFNX
AFIYH
AGMDO
AGORE
AGSYK
AHMBA
AHXPO
AIAGR
AJBYB
ALMA_UNASSIGNED_HOLDINGS
APJGH
APWMN
AQKUS
AWKKM
AZXWR
BCRHZ
BZKNY
CGNQK
CITATION
CS3
CZ4
DU5
EBS
EE~
EJD
EPA
F5P
F9B
FTD
GX1
H5~
HAR
HVGLF
HW0
HZ~
H~9
IOX
ISO
J21
KOP
KSI
KSN
M-Z
MBLQV
N4W
N9A
NAPCQ
NGC
O9-
OK1
OPA
OVD
O~Y
P2P
PHGZM
PHGZT
PQQKQ
Q5Y
R44
RD5
RNI
ROL
ROX
ROZ
RPM
RW1
RXO
RZF
SPA
TEORI
TJX
TN5
TR2
TWZ
W8F
WH7
WOQ
X7H
XOL
YNT
YYQ
YZZ
ZGI
ZPI
~91
.XZ
1KJ
5WD
70D
AABJS
AABMN
AABZA
AACZT
AAESY
AAIYJ
AAJKP
AAJQQ
AANRK
AAPBV
AAPNW
AAPQZ
AAPXW
AAUQX
AAVAP
ABIXL
ABKDP
ABNKS
ABQTQ
ABSAR
ABWST
ABZBJ
ACIMA
ACYHN
ADBBV
ADEIU
ADEYI
ADEZT
ADGZP
ADHKW
ADIPN
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADVEK
ADYVW
AEGPL
AEHKS
AEJOX
AEKSI
AENZO
AEPUE
AETBJ
AEWNT
AFDAS
AFFZL
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGUTN
AIJHB
AIKOY
AIMBJ
AJEEA
AKWXX
ALUQC
ALXQX
AOIJS
APIBT
ASMCH
AWCFO
AXUDD
AZQFJ
BAWUL
BAYMD
BEYMZ
BGYMP
BHONS
BTRTY
BVRKM
BYORX
C45
CAG
CASEJ
CDBKE
COF
DAKXR
DIK
DILTD
DPORF
DPPUQ
D~K
E3Z
EBD
EMOBN
ENERS
FA8
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
HYE
IQODW
KBUDW
M49
MHKGH
NOMLY
NOYVH
NTWIH
NU-
O0~
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OPAEJ
OWPYF
PAFKI
PEELM
Q1.
RUSNO
SV3
ULE
XJT
YAYTL
YKOAZ
YROCO
YXANX
ZA5
ZKX
AARHZ
AAUAY
ABDFA
ABNHQ
ABQNK
ABVGC
ABXVV
ADQBN
AHMMS
ATGXG
CGR
CUY
CVF
ECM
EIF
NPM
OJZSN
PKN
YIF
YIN
YR5
PKEHL
PSYQQ
7X8
ID FETCH-LOGICAL-c389t-f9c5740b8f1f54429ce1aac37bfead5d0336f4f7e36c2e427cc7ea33892adc103
ISSN 0586-7614
IngestDate Fri Jul 11 06:28:08 EDT 2025
Mon Jun 30 12:36:21 EDT 2025
Wed Feb 19 02:32:45 EST 2025
Sun Oct 22 16:07:17 EDT 2023
Thu Apr 24 23:16:11 EDT 2025
Tue Jul 01 02:40:36 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Psychosis
Pathophysiology
Postmortem
Schizophrenia
Typology
Morphometry
Pyramidal neuron
Comparative study
Hippocampus
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c389t-f9c5740b8f1f54429ce1aac37bfead5d0336f4f7e36c2e427cc7ea33892adc103
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/schizophreniabulletin/article-pdf/17/4/597/5352835/17-4-597.pdf
PMID 1805353
PQID 614418433
PQPubID 60920
PageCount 12
ParticipantIDs proquest_miscellaneous_72714230
proquest_journals_614418433
pubmed_primary_1805353
pascalfrancis_primary_5098486
crossref_primary_10_1093_schbul_17_4_597
crossref_citationtrail_10_1093_schbul_17_4_597
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1991-01-01
1991
1991-00-00
19910101
PublicationDateYYYYMMDD 1991-01-01
PublicationDate_xml – month: 01
  year: 1991
  text: 1991-01-01
  day: 01
PublicationDecade 1990
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: United States
PublicationTitle Schizophrenia bulletin
PublicationTitleAlternate Schizophr Bull
PublicationYear 1991
Publisher Oxford University Press
National Institute of Mental Health
Publisher_xml – name: Oxford University Press
– name: National Institute of Mental Health
SSID ssj0014962
Score 1.7848234
Snippet The hippocampus, an integral component of the corticolimbic circuitry of the brain, has been recently implicated in the pathophysiology of schizophrenia. This...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 597
SubjectTerms Adult and adolescent clinical studies
Affective Disorders, Psychotic - pathology
Affective Disorders, Psychotic - psychology
Biological and medical sciences
Brain
Cell Count
Hippocampus
Hippocampus - pathology
Human
Humans
Medical sciences
Neurocognitive Disorders - pathology
Neurons
Neurons - pathology
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Psychotic Disorders - pathology
Psychotic Disorders - psychology
Schizophrenia
Schizophrenia - pathology
Schizophrenic Psychology
Title Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/1805353
https://www.proquest.com/docview/614418433
https://www.proquest.com/docview/72714230
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ri9QwEA56IhzIoehhvTvNgw_C0b22SZPuo8qdi6APegf7VpI04QpeW7a7L_frnTRptqsuqFBKadI2zNdMZ9JvZhB6m3GZmKxSsZkrFVPN01jmiY6pAnO4kkJWA9v9y1e2uKGfl_lyW59wiC5Zy5m6_2Ncyf-gCucAVxsl-w_IhpvCCTgGfGEPCMP-rzD-ZvOu2v_3NsOGNSv7-n5IAtLZ0I1V3a7Ob-uug8_VXbcZOBv9hGOnxqSq_dRC_T5l4Z3LaXbuIZzHp_a_mhQibqGvX8gJa7AfaseZv_SU4spH2qUTzZMXLObMRXcGNcknrwOd6LzcEWx_08U-T5W6haHa9QE-o7Nf-oI4u7sBnLSwiWbI9qsUuIK-5SF6lIEnYHXvp2Vg8YB_N9SMDSMeszfNyYV78sX43EP02N9qxwR50okeZoNxZUz2-xmDvXH9FB15RwG_d6g_Qw908xwtPOJ4RBxbxHHd4IA4niCOW4N3EMcj4i_QzdXl9cdF7GthxApMyrWdSjmniSxManIKRoTSqRCKcGlAF-RVQggz1HBNmMo0zbhSXAsC12aiUmlCjtFB0zb6JcKM6bwSRrAiU5QzCg4CV5kBY7vS80rJCM1G8ZTKJ4q39Up-lI6wQEon2TLlJS1BshF6Fy7oXI6U_V3PduQd-oPdWtCCRehklH_pJ1pf2jULW5aIROhNaAUtaH9tiUa3m74EKzwFxyCJ0LEDbTsQh_mrfQ0n6NCx_-x2ig7Wq40-AztzLV8Pb9pPh7KA7A
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+neuronal+size+in+posterior+hippocampus+of+schizophrenic+patients&rft.jtitle=Schizophrenia+bulletin&rft.au=Benes%2C+F+M&rft.au=Sorensen%2C+I&rft.au=Bird%2C+E+D&rft.date=1991&rft.issn=0586-7614&rft.volume=17&rft.issue=4&rft.spage=597&rft_id=info:doi/10.1093%2Fschbul%2F17.4.597&rft_id=info%3Apmid%2F1805353&rft.externalDocID=1805353
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0586-7614&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0586-7614&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0586-7614&client=summon